OYE Therapeutics, Inc.
October 17, 2023
Franciscan D
CNS/Neurological
OYE is a clinical stage pharmaceutical company focused on a late stage, low risk 505(b)2 opportunity that has already achieved market adoption and uptake in the hospital market.
Speakers
Company Type
Privately Funded
Website
http://www.oyetherapeutics.com
CEO/Top Company Official
Brett Dines, RPh MBA
Lead Product in Development
OYE-101 reversal agent for general anesthesia and sedation.
Number Of Unlicensed Products
2
)
)
){kind=logo}
){kind=logo}
){kind=logo}
)
){kind=logo}
)
)